NASDAQ:NCMI - National CineMedia Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.45
  • Forecasted Upside: 0.45 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$4.43
▲ +0.08 (1.84%)
1 month | 3 months | 12 months
Get New National CineMedia Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NCMI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NCMI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$4.45
▲ +0.45% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for National CineMedia in the last 3 months. The average price target is $4.45, with a high forecast of $6.00 and a low forecast of $2.75. The average price target represents a 0.45% upside from the last price of $4.43.
Buy
The current consensus among 5 polled investment analysts is to buy stock in National CineMedia. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/27/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/25/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/24/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/23/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/21/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/19/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/13/2021BenchmarkUpgradeHold ➝ Buy$6.00N/A
i
4/7/2021BenchmarkUpgradeHold ➝ Buy$6.00High
i
4/5/2021B. RileyReiterated RatingBuy$6.00Low
i
1/25/2021B. RileyReiterated RatingBuy$4.50High
i
Rating by Eric Wold at B. Riley
11/4/2020Barrington ResearchLower Price TargetOutperform$5.50 ➝ $4.50High
i
Rating by J. Goss at Barrington Research
10/12/2020B. RileyLower Price TargetBuy$6.00 ➝ $5.00High
i
10/9/2020MKM PartnersLower Price TargetNeutral$3.00 ➝ $2.75High
i
9/8/2020B. RileyBoost Price Target$4.50 ➝ $6.00Medium
i
Rating by Eric Wold at B. Riley
9/4/2020Barrington ResearchUpgradeMarket Perform ➝ Outperform$5.50High
i
Rating by James Goss at Barrington Research
8/4/2020Barrington ResearchReiterated RatingHoldLow
i
Rating by James Goss at Barrington Research
8/4/2020B. RileyReiterated RatingBuy$4.50High
i
Rating by Eric Wold at B. Riley
7/29/2020WedbushDowngradeOutperform ➝ Neutral$4.50 ➝ $3.00High
i
Rating by M. Pachter at Wedbush
7/13/2020Barrington ResearchReiterated RatingHoldMedium
i
Rating by James Goss at Barrington Research
6/18/2020B. RileyReiterated RatingBuy$6.00Medium
i
Rating by Eric Wold at B. Riley
5/18/2020Barrington ResearchReiterated RatingHoldMedium
i
Rating by James Goss at Barrington Research
5/6/2020B. RileyReiterated RatingBuy$6.50 ➝ $6.00High
i
Rating by Eric Wold at B. Riley
5/4/2020WedbushLower Price TargetOutperform$10.00 ➝ $4.50Medium
i
4/9/2020MKM PartnersLower Price TargetNeutral$8.50 ➝ $3.00High
i
4/9/2020B. RileyReiterated RatingBuy$6.50High
i
Rating by Eric Wold at B. Riley
3/18/2020B. RileyLower Price TargetBuy$9.00 ➝ $6.50High
i
Rating by E. Wold at B. Riley
3/18/2020Barrington ResearchDowngradeOutperform ➝ Market PerformHigh
i
Rating by J. Goss at Barrington Research
3/18/2020BenchmarkDowngradeBuy ➝ HoldHigh
i
Rating by Mike Hickey at Benchmark Co.
3/2/2020B. RileyUpgradeNeutral ➝ Buy$9.00Low
i
Rating by E. Wold at B. Riley
2/27/2020Barrington ResearchReiterated RatingBuy$9.50Low
i
Rating by J. Goss at Barrington Research
2/21/2020B. RileyBoost Price TargetNeutral$7.50 ➝ $9.00High
i
Rating by E. Wold at B. Riley
2/21/2020WedbushBoost Price TargetOutperform$9.00 ➝ $10.00High
i
2/14/2020WedbushReiterated RatingBuy$9.00Low
i
11/7/2019Barrington ResearchUpgradeMarket Perform ➝ Outperform$9.50High
i
Rating by J. Goss at Barrington Research
11/5/2019WedbushReiterated RatingBuy$9.00High
i
Rating by A. Reese at Wedbush
11/5/2019B. RileyDowngradeBuy ➝ Neutral$9.75 ➝ $8.50High
i
Rating by Eric Wold at B. Riley
9/18/2019BenchmarkBoost Price TargetBuy$10.00 ➝ $12.00High
i
8/21/2019B. RileySet Price TargetBuy$10.00High
i
Rating by Eric Wold at B. Riley
6/19/2019WedbushUpgradeNeutral ➝ Outperform$8.00High
i
Rating by A. Reese at Wedbush
5/17/2019Barrington ResearchReiterated RatingMarket PerformLow
i
Rating by J. Goss at Barrington Research
5/7/2019WedbushReiterated RatingHold$8.00High
i
3/1/2019Barrington ResearchReiterated RatingHoldLow
i
9/24/2018B. RileyBoost Price TargetBuy ➝ Buy$10.50 ➝ $11.50High
i
8/7/2018MKM PartnersBoost Price TargetNeutral$9.00High
i
8/7/2018B. RileyBoost Price TargetBuy ➝ Buy$9.50 ➝ $10.50High
i
Rating by E. Wold at B. Riley
6/25/2018B. RileyBoost Price TargetBuy ➝ Buy$8.00 ➝ $9.50Low
i
Rating by E. Wold at B. Riley
5/8/2018B. RileyBoost Price TargetBuy ➝ Buy$7.00High
i
Rating by E. Wold at B. Riley
3/19/2018Barrington ResearchReiterated RatingHoldLow
i
3/19/2018B. RileyUpgradeNeutral ➝ Buy$7.00Low
i
Rating by Eric Wold at B. Riley
3/13/2018BenchmarkReiterated RatingBuy ➝ Buy$12.00 ➝ $10.00High
i
1/29/2018B. RileyDowngradeHold$8.75Low
i
Rating by Eric Wold at B. Riley
11/14/2017B. RileySet Price TargetHold$9.00N/A
i
Rating by Eric Wold at B. Riley
11/8/2017JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$5.00N/A
i
11/7/2017B. RileyDowngradeBuy ➝ Neutral$14.00 ➝ $8.75N/A
i
Rating by Eric Wold at B. Riley
9/28/2017Credit Suisse GroupLower Price TargetNeutral$8.00 ➝ $7.00Low
i
8/12/2017B. RileyReiterated RatingBuy$14.00Medium
i
Rating by Eric Wold at B. Riley
8/8/2017JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Neutral$12.00 ➝ $8.00High
i
8/7/2017B. RileySet Price TargetBuy$14.00Low
i
8/2/2017B. RileyReiterated RatingBuy$14.00High
i
8/2/2017WedbushInitiated CoverageNeutral ➝ Neutral$6.50High
i
Rating by A. Reese at Wedbush
5/23/2017B. RileyReiterated RatingBuy$14.00Low
i
5/18/2017B. RileyReiterated RatingBuy$14.00Low
i
5/15/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$17.00 ➝ $12.00Medium
i
5/15/2017Barrington ResearchDowngradeOutperform ➝ Market PerformMedium
i
Rating by J. Goss at Barrington Research
5/12/2017B. RileyReiterated RatingBuy$14.00Low
i
5/7/2017B. RileyReiterated RatingBuy$14.00High
i
5/5/2017Barrington ResearchDowngradeOutperform ➝ Market PerformHigh
i
5/5/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$17.00 ➝ $12.00High
i
5/5/2017(FBRC)DowngradeOutperform ➝ Market Perform$12.00High
i
Rating by B. Crockett at (FBRC)
5/2/2017B. RileyReiterated RatingBuy$16.00Low
i
3/15/2017Credit Suisse GroupUpgradeUnderperform ➝ Neutral$13.00 ➝ $12.00Medium
i
3/1/2017B. RileyReiterated RatingBuy$16.00N/A
i
2/24/2017B. RileyReiterated RatingBuy$18.75 ➝ $16.00N/A
i
2/24/2017(FBRC)Reiterated RatingOutperform ➝ Outperform$17.00 ➝ $14.00N/A
i
2/20/2017B. RileyReiterated RatingBuy$18.75N/A
i
2/15/2017B. RileyReiterated RatingBuy$18.75N/A
i
2/1/2017Credit Suisse GroupDowngradeOutperform ➝ Underperform$13.00N/A
i
12/28/2016WedbushReiterated RatingOutperform$17.50N/A
i
11/13/2016B. RileyReiterated RatingBuy$18.75N/A
i
11/8/2016B. RileyReiterated RatingBuy$18.75N/A
i
11/8/2016BenchmarkBoost Price TargetBuy$17.81 ➝ $18.08N/A
i
11/3/2016B. RileyReiterated RatingBuy$18.75N/A
i
8/14/2016B. RileyReiterated RatingBuy$18.75N/A
i
8/10/2016WedbushReiterated RatingOutperform$19.00 ➝ $17.50N/A
i
Rating by James Dix at Wedbush
8/9/2016B. RileyReiterated RatingBuy$20.00 ➝ $18.75N/A
i
8/9/2016(FBRC)Lower Price TargetOutperform$18.50 ➝ $17.00N/A
i
Rating by Barton Crockett at (FBRC)
8/4/2016B. RileyReiterated RatingBuy$20.00N/A
i
7/20/2016Stifel NicolausDowngradeBuy ➝ HoldN/A
i
6/13/2016Credit Suisse GroupInitiated CoverageOutperform$21.00N/A
i
6/12/2016Credit Suisse GroupReiterated RatingOutperform$21.00N/A
i
Rating by Omar Sheikh at Credit Suisse Group AG
5/26/2016(FBRC)Reiterated RatingBuyN/A
i
Rating by Barton Crockett at (FBRC)
5/10/2016B. RileyReiterated RatingBuy$20.00N/A
i
5/6/2016BenchmarkLower Price TargetBuy$19.77 ➝ $18.76N/A
i
Rating by Mike Hickey at Benchmark Co.
5/5/2016B. RileyReiterated RatingBuy$20.00N/A
i
(Data available from 4/19/2016 forward)
National CineMedia logo
National CineMedia, Inc., through its subsidiary, National CineMedia, LLC, operates cinema advertising network in North America. The company engages in the sale of advertising to national, regional, and local businesses in Noovie, a cinema advertising and entertainment pre-show seen on movie screens; and sells advertising on its Lobby Entertainment Network, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theatre lobbies. It is also involved in the sale of online and mobile advertising through its Noovie Audience Accelerator product, as well as a suite of Noovie digital properties, such as Noovie.com, Noovie Shuffle, Noovie Trivia, Name That Movie, and Noovie Arcade to reach entertainment audiences beyond the theater. The company offers its services to third-party theater circuits under long-term network affiliate agreements. National CineMedia, Inc. was incorporated in 2006 and is headquartered in Centennial, Colorado.
Read More

Today's Range

Now: $4.43
$4.23
$4.51

50 Day Range

MA: $4.81
$4.18
$5.99

52 Week Range

Now: $4.43
$1.81
$6.11

Volume

45,349 shs

Average Volume

833,234 shs

Market Capitalization

$351.52 million

P/E Ratio

N/A

Dividend Yield

4.60%

Beta

1.91

Frequently Asked Questions

What sell-side analysts currently cover shares of National CineMedia?

The following Wall Street research analysts have issued stock ratings on National CineMedia in the last year: B. Riley, Barrington Research, Benchmark Co., MKM Partners, TheStreet, Wedbush, and Zacks Investment Research.
View the latest analyst ratings for NCMI.

What is the current price target for National CineMedia?

5 Wall Street analysts have set twelve-month price targets for National CineMedia in the last year. Their average twelve-month price target is $4.45, suggesting a possible upside of 0.5%. Benchmark Co. has the highest price target set, predicting NCMI will reach $6.00 in the next twelve months. MKM Partners has the lowest price target set, forecasting a price of $2.75 for National CineMedia in the next year.
View the latest price targets for NCMI.

What is the current consensus analyst rating for National CineMedia?

National CineMedia currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NCMI will outperform the market and that investors should add to their positions of National CineMedia.
View the latest ratings for NCMI.

What other companies compete with National CineMedia?

Other companies that are similar to National CineMedia include Alphabet, Omnicom Group, The Interpublic Group of Companies, Lamar Advertising, Clear Channel Outdoor and MDC Partners.

How do I contact National CineMedia's investor relations team?

National CineMedia's physical mailing address is 6300 S. SYRACUSE WAY SUITE 300, CENTENNIAL CO, 80111. The business services provider's listed phone number is 303-792-3600 and its investor relations email address is [email protected] The official website for National CineMedia is www.ncm.com.